Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney
General of Louisiana, Charles C. Foti, Jr., remind investors that they
have until July 2, 2012, to file lead plaintiff applications in a
securities class action lawsuit against Allscripts Healthcare Solutions,
Inc. (NASDAQ: MDRX), if they purchased the Company’s common stock during
the period between November 9, 2010, and April 26, 2012, inclusive (the
"Class Period"). This action is pending in the U. S. District Court for
the Northern District of Illinois.
What You May Do
If you purchased shares of Allscripts Healthcare and would like to
discuss your legal rights and how this case might affect your right to
recover for your economic loss, you may, without obligation or cost to
you, e-mail or call KSF Managing Partner, Lewis Kahn (email@example.com),
toll free, 877-515-1850, or via cell phone any time at 504-301-7900, or
KSF Director of Client Relations, Neil Rothstein, Esq. (firstname.lastname@example.org),
toll free at 877-694-9510, or via cell phone any time at 330-860-4092.
If you wish to serve as lead plaintiff in this class action, you must
petition the Court by July 2, 2012.
About the Lawsuit
Allscripts and certain of its senior executives are charged with issuing
materially false and misleading statements, during the Class Period, in
violation of federal securities laws.
On April 27, 2012, shares of Allscripts fell $5.72, to close at $10.30,
after the Company announced operating results for 1Q:12, that were
sharply below guidance. At that time, investors first learned of the
problems that had been adversely impacting the Company throughout the
Class Period. At that time, the Company also disclosed the termination
of its Board Chairman; the resignation of three directors; and the
resignation of Allscripts’ Chief Financial Officer.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former Louisiana
Attorney General, Charles C. Foti, Jr., and other lawyers with
significant experience litigating complex securities class actions
nationwide on behalf of both institutional and individual shareholders,
you may visit www.ksfcounsel.com.